RETRACTED ARTICLE: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin, Jiwei Guo, Yan Wu, Jing Du, Lijuan Yang, Xiaohong Wang, Weihua Di, Baoguang Hu, Jiajia An, Ling–Qun Kong, Lei Pan, Guoming Su
Journal of Hematology & Oncology, 2019
Abstract
This research paper explore the methodology and findings associated with Journal of Hematology & Oncology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- MALAT1: A long non‑coding RNA highly associated with human cancers (Review) 2018
- LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis 2018
- Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway 2023
- Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer 2018
- Long noncoding RNA MALAT1 as a ceRNA drives mouse fibroblast activation via the miR-335-3p/P2ry2 axis 2024
- Long non-coding RNAs: insights into functions 2009
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation 2013
- Long non-coding RNAs: A new frontier in the study of human diseases 2013
- Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain 2014
- Identification and Validation of Long Noncoding RNA Biomarkers in Human Non–Small-Cell Lung Carcinomas 2015